Latest Capital Raises News

Cazaly Resources has issued a replacement Appendix 5B for the March 2025 quarter to correct an administrative error, reaffirming a solid cash position with over six quarters of funding available.

Oncosil Medical Ltd has announced a significant 400-for-1 security consolidation affecting shares, options, and performance rights, with shareholder approval scheduled for late May 2025.

Southern Cross Gold Consolidated Ltd has successfully arranged an upsized C$143 million funding round to fast-track its Sunday Creek Gold-Antimony Project in Victoria, Australia. This capital injection positions the company to advance drilling, underground development, and economic assessments over the coming years.

Alvo Minerals has extended the closing date for its pro-rata entitlement offer to 13 May 2025, giving shareholders additional time to subscribe to new shares and options. This move aims to support the company’s ongoing exploration ambitions in Brazil’s base and rare earth metals sectors.

Ark Mines Ltd has successfully raised A$1.5 million through a fully subscribed placement, enabling a faster development of its rare earth project in North Queensland.

Healius Limited has completed the $822 million cash sale of Lumus Imaging to Affinity Equity Partners, setting the stage for a strategic refocus on pathology and a substantial special dividend payout.

HitIQ Limited's trading suspension has been lifted following its announcement of a proposed capital raising, signaling renewed investor interest and potential growth opportunities.

HITIQ Ltd has successfully completed a $680,000 placement and launched a $2.92 million rights issue, positioning the company to fund its strategic shift towards the consumer market and expand its footprint in the US.

Platinum Asset Management has entered preliminary talks with L1 Capital about a potential merger that would combine their funds under management to approximately A$18 billion. L1 Capital has also acquired a significant stake in Platinum, signaling serious intent in this strategic consolidation.

Alice Queen Limited has voluntarily suspended trading of its shares on the ASX as it finalises a proposed capital raising, with an announcement expected by 5 May 2025.

BluGlass has completed a $2.3 million placement and launched a $6 million Share Purchase Plan to fund scaling of its GaN laser production, targeting high-growth sectors including quantum sensing and defense.

Anagenics Limited reported a cash outflow of $424K for Q3 2025 but maintains robust liquidity with $1.48 million in available funding, supported by a mix of secured and unsecured loans.